日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in Malaysia

帕博利珠单抗(MK-3475)联合铂类和吉西他滨一线治疗复发/转移性头颈部鳞状细胞癌(PIPER):一项在马来西亚开展的II期、多中心、单臂方案研究

Cheong, Sok Ching; Selvam, Bawani; Ho, Gwo Fuang; Muhamad Nor, Ibtisam; Tan, Chih Kiang; Wong, Yoke Fui; Teo, Soo Hwang; Lim, Kue Peng; Chai, Annie Wai Yeeng; Yahya, Abqariyah; Wan Ishak, Wan Zamaniah

Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

在亚太、北非和中东地区国家开展的帕唑帕尼治疗晚期或转移性肾细胞癌患者的前瞻性观察研究:PARACHUTE 研究

Erman, Mustafa; Biswas, Bivas; Danchaivijitr, Pongwut; Chen, Lingwu; Wong, Yoke Fui; Hashem, Tarek; Lim, Chun Sen; Karabulut, Bulent; Chung, Hsiao-Jen; Chikatapu, Chandrasekhar; Ingles, Sara; Slimane, Khemaies; Kanesvaran, Ravindran

Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

更正:在亚太、北非和中东地区国家开展的帕唑帕尼治疗晚期或转移性肾细胞癌患者的前瞻性观察研究:PARACHUTE 研究

Erman, Mustafa; Biswas, Bivas; Danchaivijitr, Pongwut; Chen, Lingwu; Wong, Yoke Fui; Hashem, Tarek; Lim, Chun Sen; Karabulut, Bulent; Chung, Hsiao-Jen; Chikatapu, Chandrasekhar; Ingles, Sara; Slimane, Khemaies; Kanesvaran, Ravindran

Treatment decision-making among breast cancer patients in Malaysia

马来西亚乳腺癌患者的治疗决策

Nies, Yong Hui; Islahudin, Farida; Chong, Wei Wen; Abdullah, Norlia; Ismail, Fuad; Ahmad Bustamam, Ros Suzanna; Wong, Yoke Fui; Saladina, J J; Mohamed Shah, Noraida